Detecting Pathogens Takes Too Long
Our patented CAPTURE (Confirm Active Pathogens Through Unamplified RNA Expression) technology solves this problem, and we are now developing a portable instrument to screen for hundreds of pathogens within an hour for less than $20.
GeneCapture's unique approach to disease diagnostics uses rapid RNA-based technology to bring infection detection to the Point of Care; whether that’s a hospital bed, an airport, a cruise ship, or a battlefield.
Skunk Works...
The GeneCapture team is developing a rapid COVID 19 detection system by modifying its core technology to detect Sars-CoV-2 on a paper strip. We are working with several of our partners to build and validate this solution. If successful, it will provide a detection in 25 minutes. Stay tuned for developments.
CAPTURE Technology
Using direct RNA hybridization and optical sensing, our validated pathogen detection and antibiotic sensitivity test provides rapid results for on-site, real-time decision making.
​
